SEC Company Response from PTC THERAPEUTICS, INC. (PTCT) (CIK 0001070081) (PTCT) — Jun 17, 2013
PTC THERAPEUTICS, INC. (PTCT) (CIK 0001070081)
Date: June 17, 2013 · CIK: 0001070081 · Accession: 0001104659-13-049659
AI Filing Summary & Sentiment
File numbers found in text: 333-188657
Letter
Eleven Madison Avenue New York, NY 10010 June 17, 2013 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549
Re: PTC Therapeutics, Inc. Registration Statement on Form S-1 Registration File No. 333-188657
Dear Sir/Madam:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933 (the “Act”), we, as representatives of the several Underwriters, wish to advise you that 3,008 copies of the Preliminary Prospectus included in the Registration Statement on Form S-1 were distributed during the period June 5, 2013 through 5:00 p.m. Eastern time, June 14, 2013, to prospective underwriters, institutions, dealers and others.
We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934.
In accordance with Rule 461 of the Act, we hereby join in the request of PTC Therapeutics, Inc. for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:00 p.m. Eastern time on June 19, 2013, or as soon thereafter as practicable.
[Remainder of page intentionally left blank]
Very truly yours,
By:
Show Raw Text
CORRESP
1
filename1.htm
J.P. MORGAN SECURITIES LLC
383 Madison Avenue
New York, NY 10179
CREDIT SUISSE SECURITIES (USA) LLC
Eleven Madison Avenue
New York, NY 10010
June 17, 2013
Re: PTC Therapeutics, Inc.
Registration Statement on Form S-1
Registration File No. 333-188657
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Dear Sir/Madam:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933 (the “Act”), we, as representatives of the several Underwriters, wish to advise you that 3,008 copies of the Preliminary Prospectus included in the Registration Statement on Form S-1 were distributed during the period June 5, 2013 through 5:00 p.m. Eastern time, June 14, 2013, to prospective underwriters, institutions, dealers and others.
We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934.
In accordance with Rule 461 of the Act, we hereby join in the request of PTC Therapeutics, Inc. for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:00 p.m. Eastern time on June 19, 2013, or as soon thereafter as practicable.
[Remainder of page intentionally left blank]
Very truly yours,
By:
J.P. MORGAN SECURITIES LLC
By:
/s/ Sri Kosaraju
Name:
Sri Kosaraju
Title:
Managing Director
By:
CREDIT SUISSE SECURITIES (USA) LLC
By:
/s/ Jill Ford
Name:
Jill Ford
Title:
Managing Director